BRPI0923599A2 - vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo - Google Patents
vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeoInfo
- Publication number
- BRPI0923599A2 BRPI0923599A2 BRPI0923599A BRPI0923599A BRPI0923599A2 BR PI0923599 A2 BRPI0923599 A2 BR PI0923599A2 BR PI0923599 A BRPI0923599 A BR PI0923599A BR PI0923599 A BRPI0923599 A BR PI0923599A BR PI0923599 A2 BRPI0923599 A2 BR PI0923599A2
- Authority
- BR
- Brazil
- Prior art keywords
- swine fever
- classical swine
- fever virus
- animals
- vaccine
- Prior art date
Links
- 241000710777 Classical swine fever virus Species 0.000 title 4
- 241001465754 Metazoa Species 0.000 title 4
- 208000001726 Classical Swine Fever Diseases 0.000 title 2
- 208000015181 infectious disease Diseases 0.000 title 2
- 230000002458 infectious effect Effects 0.000 title 2
- 229960005486 vaccine Drugs 0.000 title 2
- 206010037660 Pyrexia Diseases 0.000 title 1
- 241000282898 Sus scrofa Species 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08172874A EP2202298A1 (en) | 2008-12-23 | 2008-12-23 | Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
| PCT/NL2009/050801 WO2010074575A2 (en) | 2008-12-23 | 2009-12-23 | Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0923599A2 true BRPI0923599A2 (pt) | 2019-09-24 |
Family
ID=40601213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0923599A BRPI0923599A2 (pt) | 2008-12-23 | 2009-12-23 | vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8911744B2 (pt) |
| EP (2) | EP2202298A1 (pt) |
| JP (1) | JP5868182B2 (pt) |
| CN (1) | CN102317449B (pt) |
| BR (1) | BRPI0923599A2 (pt) |
| ES (1) | ES2546403T3 (pt) |
| HU (1) | HUE025711T2 (pt) |
| MX (1) | MX2011006846A (pt) |
| RU (1) | RU2501854C2 (pt) |
| WO (1) | WO2010074575A2 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2202298A1 (en) * | 2008-12-23 | 2010-06-30 | Stichting Dienst Landbouwkundig Onderzoek | Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
| MX337048B (es) * | 2010-05-18 | 2016-02-11 | Riemser Arzneimittel Ag | Vacuna marcadora para la fiebre porcina clasica. |
| CN103751773B (zh) * | 2013-07-17 | 2016-05-18 | 哈尔滨维科生物技术开发公司 | 稳定表达猪瘟病毒e0-e1-e2蛋白的重组bhk细胞系及其在制备猪瘟疫苗与诊断试剂中的应用 |
| RU2689143C1 (ru) * | 2013-12-19 | 2019-05-24 | Интервет Интернэшнл Б.В. | Усовершенствованный диагностический тест для csfv антител |
| WO2015177369A1 (en) * | 2014-05-23 | 2015-11-26 | Boehringer Ingelheim Vetmedica Gmbh | Recombinant classical swine fever virus (csfv) comprising substitution in the tav epitope of the e2 protein |
| CN105242044A (zh) * | 2015-11-23 | 2016-01-13 | 新疆天康畜牧生物技术股份有限公司 | 猪瘟病毒e2蛋白定量的检测方法 |
| CN107828745B (zh) * | 2017-11-15 | 2021-01-05 | 中国兽医药品监察所 | 猪瘟兔化弱毒表位突变株及其应用 |
| CN109781980A (zh) * | 2019-01-30 | 2019-05-21 | 河南中泽生物工程有限公司 | 非洲猪瘟病毒快速检测卡及其应用 |
| CN113748203B (zh) * | 2019-04-18 | 2024-12-20 | 勃林格殷格翰动物保健(中国)有限公司 | 重组经典猪瘟病毒 |
| GB201910794D0 (en) * | 2019-07-29 | 2019-09-11 | Pirbright Inst | Vaccine |
| CN113106071A (zh) * | 2020-01-13 | 2021-07-13 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | Hq06表位突变的猪瘟候选标记疫苗株及其应用 |
| CN111718400B (zh) * | 2020-06-15 | 2021-11-02 | 苏州世诺生物技术有限公司 | 猪瘟病毒重组抗原及其制备方法和应用 |
| CN112625091B (zh) * | 2020-12-25 | 2023-03-31 | 龙湖现代免疫实验室 | 一条结合猪瘟病毒Erns蛋白的多肽序列及应用 |
| CN112707948B (zh) * | 2020-12-25 | 2023-03-31 | 龙湖现代免疫实验室 | 一条结合猪瘟病毒e0蛋白的多肽序列及应用 |
| EP4105225A1 (en) * | 2021-06-18 | 2022-12-21 | Institut de Recerca i Tecnologia Agroalimentàries | Peptide-based assay to differentiate animals infected with csfv from vaccinated animals |
| CN113512098B (zh) * | 2021-07-15 | 2022-08-23 | 武汉大学 | 鉴别猪瘟病毒和牛病毒性腹泻病毒血清抗体间接elisa方法及其应用 |
| CN114574503B (zh) * | 2022-03-14 | 2024-03-29 | 成都史纪生物制药有限公司 | 一种猪瘟E2蛋白基因、猪伪狂犬病毒gD蛋白基因及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149527A (en) | 1990-09-18 | 1992-09-22 | Oncotech, Inc. | Immunopotentiating protocol for chemotherapy-responsive tumors |
| HU220746B1 (hu) * | 1994-06-17 | 2002-05-28 | Instituut Voor Veehouderij En Diergezondheid | Pestivírustörzsekből izolált nukleotidszekvenciák, az általuk kódolt polipeptidek és ezek alkalmazása pestivírus-fertőzések diagnosztizálására és megelőzésére |
| US6316007B1 (en) | 1995-04-04 | 2001-11-13 | Wound Healing Of Oklahoma | Combined physical and immunotherapy for cancer |
| EP0924298A1 (en) | 1997-12-18 | 1999-06-23 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Protein expression in baculovirus vector expression systems |
| PT1104306E (pt) | 1998-08-10 | 2006-05-31 | Antigenics Inc | Composicoes de cpg e adjuvantes de saponina e seus metodos |
| EP1035205A1 (en) * | 1999-03-08 | 2000-09-13 | Stichting Dienst Landbouwkundig Onderzoek | Non-spreading pestivirus |
| JP5250179B2 (ja) * | 2002-11-08 | 2013-07-31 | ザ アドミニストレイターズ オブ ザ テューレイン エデュケイショナル ファンド | フラビウイルス融合インヒビター |
| GB0323968D0 (en) | 2003-10-13 | 2003-11-19 | Glaxosmithkline Biolog Sa | Immunogenic compositions |
| US8846055B2 (en) * | 2006-05-30 | 2014-09-30 | The United States Of America, As Represented By The Secretary Of Agriculture | Virulence determinant within the E2 structural glycoprotein of classical swine fever virus |
| US8133495B2 (en) * | 2007-05-22 | 2012-03-13 | The United States Of America As Represented By The Secretary Of Agriculture | Live attenuated antigenically marked classical swine fever virus |
| EP2202298A1 (en) * | 2008-12-23 | 2010-06-30 | Stichting Dienst Landbouwkundig Onderzoek | Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
-
2008
- 2008-12-23 EP EP08172874A patent/EP2202298A1/en not_active Withdrawn
-
2009
- 2009-12-23 HU HUE09775363A patent/HUE025711T2/en unknown
- 2009-12-23 EP EP09775363.6A patent/EP2382307B1/en active Active
- 2009-12-23 US US13/141,182 patent/US8911744B2/en not_active Expired - Fee Related
- 2009-12-23 RU RU2011130829/10A patent/RU2501854C2/ru active
- 2009-12-23 WO PCT/NL2009/050801 patent/WO2010074575A2/en not_active Ceased
- 2009-12-23 ES ES09775363.6T patent/ES2546403T3/es active Active
- 2009-12-23 JP JP2011543453A patent/JP5868182B2/ja not_active Expired - Fee Related
- 2009-12-23 CN CN200980156450.7A patent/CN102317449B/zh active Active
- 2009-12-23 MX MX2011006846A patent/MX2011006846A/es active IP Right Grant
- 2009-12-23 BR BRPI0923599A patent/BRPI0923599A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102317449B (zh) | 2014-07-23 |
| ES2546403T3 (es) | 2015-09-23 |
| JP5868182B2 (ja) | 2016-02-24 |
| HUE025711T2 (en) | 2016-04-28 |
| US20110287044A1 (en) | 2011-11-24 |
| EP2202298A1 (en) | 2010-06-30 |
| WO2010074575A2 (en) | 2010-07-01 |
| JP2012513212A (ja) | 2012-06-14 |
| US8911744B2 (en) | 2014-12-16 |
| EP2382307B1 (en) | 2015-07-15 |
| EP2382307A2 (en) | 2011-11-02 |
| RU2011130829A (ru) | 2013-01-27 |
| RU2501854C2 (ru) | 2013-12-20 |
| WO2010074575A3 (en) | 2010-08-26 |
| MX2011006846A (es) | 2011-09-09 |
| CN102317449A (zh) | 2012-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0923599A2 (pt) | vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo | |
| HUE043952T2 (hu) | Módosított influenzavírus vakcinahatékonyság monitorozására és javítására | |
| PL2281831T3 (pl) | Szczepionka przeciw wirusowi ospy wietrznej i półpaśca | |
| EP2998315A3 (en) | Newcastle disease virus vectored avian vaccines | |
| MX341842B (es) | Virus de la influenza capaces de infectar canidos y usos de los mismos. | |
| CY1117673T1 (el) | Ανασυνδυασμενα αντιγονα rsv | |
| EA201071087A1 (ru) | Моноклональные антитела, способные взаимодействовать с множеством подтипов вируса гриппа а | |
| IL198466A (en) | Use of dengue fever vaccines to produce a single-value vaccine and four-value vaccine to vaccinate against dengue fever virus and vaccine kits against dengue fever containing these vaccines | |
| IL186710A (en) | Influenza A virus is isolated from dogs, a drug and vaccine that include it and its use | |
| WO2008121329A3 (en) | Turkey herpesvirus vectored recombinant containing avian influenza genes | |
| BR112012023046A2 (pt) | vacinas de vírus de febre aftosa recombinantes e seus respectivos usos | |
| DK1881845T3 (da) | Nipah-virusvacciner | |
| DK1968632T3 (da) | Forbedret influenzavaccine | |
| AR060565A1 (es) | Vacuna para la gripe aviaria y metodos de uso | |
| CY1113540T1 (el) | Εμβολια γριππης σκυλων | |
| EA201001045A1 (ru) | Модифицированный вирус гриппа | |
| BRPI1011034A2 (pt) | vacina de gripe universal baseada no vírus ancara vaccinia modificado (mva) recombinante | |
| EP2437778A4 (en) | RECOMBINANT WESTNILVIRUS SUBSIDIARY VACCINE FOR THE PROTECTION OF HUMAN LIFE | |
| ATE490782T1 (de) | Chimäre vakzine-antigene gegen das klassische schweinefieber-virus | |
| CO7461133A2 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
| BRPI0822947A2 (pt) | Vacina recombinante, método para vacinação contra doenças de animais e método para identificação entre animais infectados e animais vacinados | |
| CO7461135A2 (es) | Parvovirus porcino 5b, métodos de uso y vacuna | |
| AR047581A1 (es) | Vacunas de calicivirus felino | |
| EA201290319A1 (ru) | Применение источника l3 и/или l5 в качестве вакцины или диагностического средства для паразитарного заболевания | |
| BRPI0817230A2 (pt) | vacina contra influenza inativada, e, uso da vacina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law | ||
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |